We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 13, 2020

Among Non-Users of Aspirin, PIK3CA Mutations Are Associated With Longer Time to Metastasis and Reduced Mortality

BMC Cancer


Additional Info

BMC Cancer
Different Associations of Tumor PIK3CA Mutations and Clinical Outcomes According to Aspirin Use Among Women With Metastatic Hormone Receptor Positive Breast Cancer
BMC Cancer 2020 Apr 23;[EPub Ahead of Print], AM McCarthy, NP Kumar, W He, S Regan, M Welch, B Moy, AJ Iafrate, AT Chan, A Bardia, K Armstrong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading